Interleukin 11 therapy causes acute heart failure and its use in patients should be reconsidered
Mark D. Sweeney, Katie O’Fee, Chelsie Villanueva-Hayes, Ekhlas Rahman, Michael Lee, Henrike Maatz, Eric L. Lindberg, Konstantinos Vanezis, Ivan Andrew, Emma R. Jennings, Wei‐Wen Lim, Anissa Anindya Widjaja, Norbert Hübner, Paul J.R. Barton, Stuart A. Cook
This paper identifies direct cardiomyocyte toxicities of IL11 therapy, showing it causes acute heart failure by activating JAK/STAT3, which questions its continued use in patients.
bioRxiv · Sep 30, 2023 · PreprintMolecular Biology